People
Matt Blaschke focuses on complex litigation involving scientific or technical issues, as well as general litigation. As a partner in our Environmental and Mass Tort and Toxic Tort practices, Matt represents energy, pharmaceutical, consumer product and chemical industry clients in state and federal courts throughout the country.
Matt’s experience ranges from large-scale multiparty litigation to individual product liability actions. He also advises clients on environmental laws and regulations, including the federal Insecticide, Fungicide and Rodenticide Act.
J.D., George Washington University, honors
B.A., Notre Dame
California
District of Columbia
U.S. District Court for the Central District of California
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Currently representing a large energy company in mass tort litigation arising from facility fire in California.
Member of national coordinating team of lawyers representing GlaxoSmithKline (“GSK”) in product liability litigation throughout the country, including allegations that the antidepressant Paxil® causes congenital defects. Matt has prepared numerous cases for trial; deposed plaintiffs as well as third-party witnesses and treating physicians; developed and executed pretrial strategy; briefed dispositive and procedural motions; and coordinated discovery.
Defended GSK before Pennsylvania appellate courts following summary judgment for GSK in product liability litigation including allegations that Paxil® caused congenital defects.
See more
May 20, 2020
COVID-19 Return to Work Q&A: Premises Liability Issues
April 23, 2020
Is Plastics Litigation the Next Public Nuisance?
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
Currently representing a large energy company in mass tort litigation arising from facility fire in California.
Member of national coordinating team of lawyers representing GlaxoSmithKline (“GSK”) in product liability litigation throughout the country, including allegations that the antidepressant Paxil® causes congenital defects. Matt has prepared numerous cases for trial; deposed plaintiffs as well as third-party witnesses and treating physicians; developed and executed pretrial strategy; briefed dispositive and procedural motions; and coordinated discovery.
Defended GSK before Pennsylvania appellate courts following summary judgment for GSK in product liability litigation including allegations that Paxil® caused congenital defects.
See more
May 20, 2020
COVID-19 Return to Work Q&A: Premises Liability Issues
April 23, 2020
Is Plastics Litigation the Next Public Nuisance?
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
J.D., George Washington University, honors
B.A., Notre Dame
California
District of Columbia
U.S. District Court for the Central District of California
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California